tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sumant Kulkarni, 197 are a BUY (89.55%), 22 are a HOLD (10%), 1 are a SELL (0.45%).
Analyst Sumant Kulkarni, currently employed at CANACCORD, carries an average stock price target met ratio of 33.41% that have a potential upside of 27.22% achieved within 233 days.
Sumant Kulkarni’s has documented 420 price targets and ratings displayed on 28 stocks. The coverage is on Healthcare, Industrials, Technology sectors.
Most recent stock forecast was given on ATAI, ATAI Life Sciences BV at 07-Jul-2026.
Analyst best performing recommendations are on CARA (CARA THERAPEUTIC).
The best stock recommendation documented was for CARA (CARA THERAPEUTIC) at 6/13/2024. The price target of $10 was fulfilled within 4 days with a profit of $5.97 (37.38%) receiving and performance score of 93.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jun-2025
$36
$9.78 (37.30%)
$30
7 days ago
(07-Jul-2026)
0/7 (0%)
$9.8 (37.40%)
Buy Since 30-Jun-2026
$30
$3.78 (14.42%)
$29
14 days ago
(30-Jun-2026)
10/13 (76.92%)
$4.7 (18.58%)
275
Buy Since 21-Oct-2025
$35
$8.78 (33.49%)
$32
15 days ago
(29-Jun-2026)
0/4 (0%)
$9.8 (38.89%)
Buy Since 01-Mar-2024
$34
$8.68 (34.28%)
$31
4 months 10 days ago
(04-Mar-2026)
8/15 (53.33%)
$10.61 (45.36%)
113
Buy Since 26-Nov-2019
$35
$9.68 (38.23%)
$34
4 months 18 days ago
(26-Feb-2026)
7/20 (35%)
$10.36 (42.05%)
274
Which stock is Sumant Kulkarni is most bullish on?
Which stock is Sumant Kulkarni is most reserved on?
What Year was the first public recommendation made by Sumant Kulkarni?
